Sign In
deCODE Genetics Inc. (DCGN)
SHARE
Email Confirmation
Dr. Kari Stefansson, M.D.
, Founder/CEO/Chairman of the Board/President/Director
Industry: Professional Services
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Dr. Kari Stefansson, M.D., Founder/CEO/Chairman of the Board/President/Director
Sturlugata 8
IS-101
Reykjavik,
IC
Map it 
Overview
A biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases.
Press Releases
-
It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer Jul-06-2009, 07:07AM EDT
-
deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia Jul-01-2009, 01:20PM EDT
-
deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis Jun-29-2009, 08:14AM EDT
-
The following is an investment opinion release issued by Pennystockchaser.com Jun-27-2009, 01:10PM EDT
-
deCODE Reinstated to Nasdaq Global Market Jun-26-2009, 08:14AM EDT
News From Around the Web
News
-
Your Genome is Just a Click Away (Computerworld)Jul 07 2009
-
NHS is ill-equipped to use genetic tests (London Times)Jul 06 2009
Employees
Number of Employees: 431
Revenue per Employee: $89,769
Financials
Quarterly
Annual
| Income Statement | 12/2008 | 09/2008 | 05/2008 | 03/2008 |
|---|---|---|---|---|
| Sales | 11.71 Mil. | 11.14 Mil. | 11.73 Mil. | 12.54 Mil. |
| Gross Operating Profit | 266 K. | 3.89 Mil. | 3.25 Mil. | 799 K. |
| Operating Income before D & A (EBITDA) | -12.05 Mil. | -11.22 Mil. | -16.61 Mil. | -19.5 Mil. |
| Total Income Before Interest Expenses (EBIT) | -13.71 Mil. | -14.23 Mil. | -22.64 Mil. | -28.27 Mil. |
| Total Net Income | -17.9 Mil. | -18.35 Mil. | -26.66 Mil. | -32.42 Mil. |
| Basic EPS, Total | -0.29 | -0.3 | -0.44 | -0.54 |
| Diluted EPS, Total | -0.29 | -0.3 | -0.44 | -0.54 |
| BALANCE STATEMENT | 12/2008 | 09/2008 | 05/2008 | 03/2008 |
|---|---|---|---|---|
| Cash and Equivalents | 11.78 Mil. | 18.24 Mil. | 42.73 Mil. | 54.17 Mil. |
| Total Assets | 35.86 Mil. | 44.31 Mil. | 65.19 Mil. | 82.65 Mil. |
| Total Liabilities | 37.05 Mil. | 30.28 Mil. | 36.14 Mil. | 34.26 Mil. |
| Total Capitalization | 10.99 Mil. | 26.72 Mil. | 66.92 Mil. | 65.61 Mil. |
| Cash Flow | 12/2008 | 09/2008 | 05/2008 | 03/2008 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | -47.53 Mil. | -37.98 Mil. | -20.03 Mil. | -63.89 Mil. |
| Net Cash From Investing Activities | 7.82 Mil. | 3.73 Mil. | 9.29 Mil. | 78.53 Mil. |
| Net Cash From Financing Activities | -2.68 Mil. | -1.68 Mil. | -704 K. | 17.65 Mil. |
| Net Change in Cash & Cash Equivalents | -42.39 Mil. | -35.93 Mil. | -11.44 Mil. | 32.29 Mil. |
| Income Statement | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Sales | 37.01 Mil. | 36.03 Mil. | 30.1 Mil. | 28.4 Mil. |
| Gross Operating Profit | 3.39 Mil. | 4.48 Mil. | 13.86 Mil. | 13.73 Mil. |
| Operating Income before D & A (EBITDA) | -77.57 Mil. | -77.84 Mil. | -50.01 Mil. | -31.4 Mil. |
| Total Income Before Interest Expenses (EBIT) | -79.88 Mil. | -77.66 Mil. | -55.27 Mil. | -48.27 Mil. |
| Total Net Income | -95.53 Mil. | -85.47 Mil. | -62.75 Mil. | -57.26 Mil. |
| Basic EPS, Total | -1.57 | -1.49 | -1.17 | -1.07 |
| Diluted EPS, Total | -1.57 | -1.49 | -1.17 | -1.07 |
| BALANCE STATEMENT | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Cash and Equivalents | 54.17 Mil. | 21.88 Mil. | 65.94 Mil. | 70.24 Mil. |
| Total Assets | 82.65 Mil. | 169.71 Mil. | 166.95 Mil. | 203.08 Mil. |
| Total Liabilities | 34.26 Mil. | 23.5 Mil. | 25.52 Mil. | 37.91 Mil. |
| Total Capitalization | 65.61 Mil. | 156.68 Mil. | 146.32 Mil. | 241.93 Mil. |
| Cash Flow | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | -63.89 Mil. | -85.17 Mil. | -54.03 Mil. | -29.94 Mil. |
| Net Cash From Investing Activities | 78.53 Mil. | -44.42 Mil. | 95.83 Mil. | -124.65 Mil. |
| Net Cash From Financing Activities | 17.65 Mil. | 85.53 Mil. | -46.09 Mil. | 156.16 Mil. |
| Net Change in Cash & Cash Equivalents | 32.29 Mil. | -44.06 Mil. | -4.3 Mil. | 1.57 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
209.85 Mil.
206.46 Mil.
237.17 Mil.
239.89 Mil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.
RSS Most Read